Abstract
Replacing an adamantyl unit in the protein kinase inhibitor Opaganib® with an integrated [(η$^{5}$-Cp)M(CO)$_{3}$] (M = Re, 99mTc) unit retains the lead's bioactivity and yields a true matched-pair pharmacomimetic.
Navigation auf zora.uzh.ch
Lengacher, Raphael; Wang, Youchao; Braband, Henrik; Blacque, Olivier; Gasser, Gilles; Alberto, Roger (2021). Organometallic small molecule kinase inhibitors – direct incorporation of Re and 99mTc into Opaganib®. Chemical Communications, 57(98):13349-13352.
Replacing an adamantyl unit in the protein kinase inhibitor Opaganib® with an integrated [(η$^{5}$-Cp)M(CO)$_{3}$] (M = Re, 99mTc) unit retains the lead's bioactivity and yields a true matched-pair pharmacomimetic.
Item Type: | Journal Article, refereed, original work |
---|---|
Communities & Collections: | 07 Faculty of Science > Department of Chemistry |
Dewey Decimal Classification: | 540 Chemistry |
Scopus Subject Areas: | Physical Sciences > Catalysis
Physical Sciences > Electronic, Optical and Magnetic Materials Physical Sciences > Ceramics and Composites Physical Sciences > General Chemistry Physical Sciences > Surfaces, Coatings and Films Physical Sciences > Metals and Alloys Physical Sciences > Materials Chemistry |
Uncontrolled Keywords: | Materials Chemistry, Metals and Alloys, Surfaces, Coatings and Films, General Chemistry, Ceramics and Composites, Electronic, Optical and Magnetic Materials, Catalysis |
Language: | English |
Date: | 1 January 2021 |
Deposited On: | 13 Jan 2022 14:39 |
Last Modified: | 16 Mar 2025 04:35 |
Publisher: | Royal Society of Chemistry |
ISSN: | 1359-7345 |
OA Status: | Hybrid |
Free access at: | Publisher DOI. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1039/d1cc03678e |
Project Information: |
|